Meridian Bioscience, Inc. (VIVO) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.70 +3.30%
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
CCEL, FNGR, FAST, More
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $44.34 million.
Meridian Bioscience, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Meridian Bioscience, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- SonicStrategy signs LOI to acquire AI assets from ARKLAB AI
- HCA Healthcare cuts 2026 profit outlook on insurance exchange losses
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
